###begin article-title 0
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Identification of novel mutations and sequence variants in the SOX2 and CHX10 genes in patients with anophthalmia/microphthalmia
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
Mutations in the SOX2 and CHX10 genes have been reported in patients with anophthalmia and/or microphthalmia. In this study, we evaluated 34 anophthalmic/microphthalmic patient DNA samples (two sets of siblings included) for mutations and sequence variants in SOX2 and CHX10.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 210 217 <span type="species:ncbi:9606">Patient</span>
###xml 373 380 <span type="species:ncbi:9606">patient</span>
Conformational sensitive gel electrophoresis (CSGE) was used for the initial SOX2 and CHX10 screening of 34 affected individuals (two sets of siblings), five unaffected family members, and 80 healthy controls. Patient samples containing heteroduplexes were selected for sequence analysis. Base pair changes in SOX2 and CHX10 were confirmed by sequencing bidirectionally in patient samples.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 929 934 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 157 164 <span type="species:ncbi:9606">patient</span>
###xml 715 722 <span type="species:ncbi:9606">patient</span>
###xml 906 914 <span type="species:ncbi:9606">patients</span>
Two novel heterozygous mutations and two sequence variants (one known) in SOX2 were identified in this cohort. Mutation c.310 G>T (p. Glu104X), found in one patient, was in the region encoding the high mobility group (HMG) DNA-binding domain and resulted in a change from glutamic acid to a stop codon. The second mutation, noted in two affected siblings, was a single nucleotide deletion c.549delC (p. Pro184ArgfsX19) in the region encoding the activation domain, resulting in a frameshift and premature termination of the coding sequence. The shortened protein products may result in the loss of function. In addition, a novel nucleotide substitution c.*557G>A was identified in the 3'-untranslated region in one patient. The relationship between the nucleotide change and the protein function is indeterminate. A known single nucleotide polymorphism (c. *469 C>A, SNP ) was also detected in 2 of the 34 patients. Screening of CHX10 identified two synonymous sequence variants, c.471 C>T (p.Ser157Ser, ) and c.579 G>A (p. Gln193Gln, novel SNP), and one non-synonymous sequence variant, c.871 G>A (p. Asp291Asn, novel SNP). The non-synonymous polymorphism was also present in healthy controls, suggesting non-causality.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 185 192 <span type="species:ncbi:9606">patient</span>
These results support the role of SOX2 in ocular development. Loss of SOX2 function results in severe eye malformation. CHX10 was not implicated with microphthalmia/anophthalmia in our patient cohort.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 184 185 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
Anophthalmia (an absence of eye structures) and/or microphthalmia (an abnormally small eye) are rare disorders with a prevalence of 0.2-0.4 per 10,000 births in developed countries [1-3]. One or both eyes are affected in isolation or as part of other birth defects [4-9]. The disease exhibits diverse patterns of genetic inheritance, and the severity is variable due to the genetic heterogeneity of the ocular malformation.
###end p 11
###begin p 12
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 553 560 <span type="species:ncbi:8355">Xenopus</span>
Mutations in several human genes are associated with anophthalmia and microphthalmia. Among them, mutations in SOX2 appear to account for most cases [4,10-14]. SOX2, which is located at chromosome 3q26.3-q27, encodes 317 amino acids that belong to the high-mobility-group (HMG) DNA-binding protein family. Expressed in embryonic stem cells and a wide variety of tissues during early development, SOX2 plays an important role in cell differentiation and early organogenesis [15,16]. In ocular tissues, the inhibition of SOX2 expression in the developing Xenopus retina has been shown to reduce cell proliferation and allows cells to develop into non-neuronal cell types [17]. Working in concert with PAX6, SOX2 regulates downstream target genes such as the crystalline genes to guide early lens development [18].
###end p 12
###begin p 13
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 747 751 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
Mutations in SOX2 account for approximately 10% of anophthalmia and microphthalmia cases [4,10,19]. Previously reported cases of anophthalmia and microphthalmia were associated with SOX2 whole-gene deletions or coding sequence mutations [4,10-13,19,20]. In this study, a cohort of 34 anophthalmia/microphthalmia patients was screened for mutations in SOX2. Two novel heterozygous mutations and two sequence variants (one novel, one known SNP) were identified in 6 (two siblings) out of 34 patients. This confirms the importance of SOX2 mutation screening in patients with anophthalmia/microphthalmia. In screening unaffected family members, we also found an individual with a pathogenic allele suggesting the novel finding that autosomal dominant SOX2 mutations can be non-penetrant.
###end p 13
###begin p 14
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 277 283 <span type="species:ncbi:9606">humans</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 658 666 <span type="species:ncbi:9606">patients</span>
As part of our large scale screening campaign, mutation analysis of CHX10 was also performed. The homeodomain protein CHX10 has been shown to be essential for ocular development [21], and autosomal recessive mutations of the gene have been implicated in microphthalmia in both humans and mice [22-24]. Screening of the same cohort of anophthalmia/microphthalmia patients identified two synonymous sequence variants in exon 3 and one non-synonymous sequence variant in exon 5. This non-synonymous polymorphism was also present in normal controls. We did not find sequence variants in other exons of CHX10, suggesting that CHX10 mutations are less frequent in patients with anophthalmia.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 295 302 <span type="species:ncbi:9606">Patient</span>
###xml 397 402 <span type="species:ncbi:9606">Human</span>
###xml 427 435 <span type="species:ncbi:9606">Children</span>
To identify existing and potentially novel mutations of SOX2 and CHX10 in a cohort of anophthalmia and microphthalmia patients, we undertook a candidate gene screening approach. We screened 34 affected individuals (two sets of siblings), five unaffected family members, and 80 healthy controls. Patient demographics are summarized in . The study was approved by the Institutional Review Board for Human Subject Research at the Children's Hospital of Philadelphia and at the Albert Einstein Medical Center. The study also conformed to the tenets of the Declaration of Helsinki. Informed consent was obtained from all subjects whose blood and DNA samples were used in the analysis. Peripheral blood samples (10-20 ml) were collected, and genomic DNA was extracted using the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN).
###end p 17
###begin title 18
Conformation-sensitive-gel-electrophoresis
###end title 18
###begin p 19
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 574 575 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 625 628 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 961 965 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 970 975 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 861 868 <span type="species:ncbi:9606">Patient</span>
###xml 1024 1031 <span type="species:ncbi:9606">patient</span>
Conformation-sensitive-gel-electrophoresis (CSGE) was used for initial SOX2 and CHX10 gene screenings. Standard polymerase chain reaction (PCR) was performed on genomic DNA of affected patients, unaffected relatives, and healthy controls to amplify SOX2 and CHX10 exonic sequences (primer sets are available upon request). An additional 120 base pairs of intronic sequences at both the 5'-end and 3'-end were also included. PCR amplification was performed in a reaction volume of 25 mul containing 50 ng of genomic DNA, 200 muM dNTP, 0.4 muM of each primer pair, 1.5 mM MgCl2, 1X PCR buffer, 1X Q-solution, and 1.25 units of Taq polymerase (Qiagen, Valencia, CA). A single annealing temperature of 55 degreesC was used for all primers. PCR products were separated by electrophoresis in an 8% polyacrylamide gel for detection of heteroduplexes and homoduplexes. Patient samples containing heteroduplexes were selected for sequence analysis. Base pair changes in SOX2 and CHX10 were confirmed by sequencing bidirectionally in patient samples.
###end p 19
###begin title 20
Results
###end title 20
###begin p 21
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 199 207 199 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 10 18 <span type="species:ncbi:9606">patients</span>
###xml 269 276 <span type="species:ncbi:9606">patient</span>
###xml 740 747 <span type="species:ncbi:9606">patient</span>
###xml 845 853 <span type="species:ncbi:9606">patients</span>
Of the 34 patients (32 independent probands) analyzed, three (two siblings) showed novel mutations in coding sequence and three had two sequence variants in the 3'-untranslated region (UTR) of SOX2 (Figure 1 and Table 1). Mutation, c.310 G>T (p. Glu104X), found in one patient, was in the region encoding the HMG DNA-binding domain and resulted in a change from glutamic acid to a stop codon. The second mutation, noted in two affected siblings, was a single nucleotide deletion c.549delC (p. Pro184ArgfsX19) in the region encoding the activation domain, resulting in a frameshift and premature termination of the coding sequence. In addition, a novel nucleotide substitution, c.*557G>A, was identified in the 3'-untranslated region in one patient, and a known single nucleotide polymorphism (c. *469 C>A, SNP ) was also detected in 2 out of 34 patients ().
###end p 21
###begin p 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
SOX2 gene structure and mutations in anophthalmia/microphthalmia. The 5'- and 3'- untranslated regions are shown as blank boxes, and the coding region is shown as a filled box. The start (ATG) and the stop (TGA) codons are indicated. Mutations detected in this study are indicated. The nuclear targeting sequence is underlined. HMG=high mobility group, G=guanosine, T=thymidine, C=cytidine, A=adenosine, Glu=glutamic acid, Pro=proline, Arg=arginine, X=stop, FS=frameshift.
###end p 22
###begin title 23
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
Sequence variations in SOX2.
###end title 23
###begin p 24
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 982 983 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
The entire genomic sequence of SOX2 was screened by CSGE. Samples which show heteroduplex, triplet, and quadruplet on CSGE are sequenced bi-directionally. Homoduplex indicates two identical alleles. Heteroduplex, triplet, and quadruplet indicate different alleles. One allele is the wild type sequence and the other one is a sequence variant differing from the wild type one. Novel mutation at c.310 G>T results in a nonsense amino acid change at p. Glu104X. The novel single nucleotide deletion at c.549delC results in a frame shift mutation and premature termination at 19 amino acids downstream of the deletion site (p.Pro184ArgfsX19). The novel single nucleotide substitution at c.*557G>A is in the 3'-UTR and does not predictably change the SOX2 protein. Another single nucleotide substitution at *469 C>A is a known SNP (rs11915160) located in the 3'-UTR. G=guanosine, T=thymidine, C=cytidine, A=adenosine, Glu=glutamic acid, Pro=proline, Arg=arginine, X=Stop, FS=frameshift; 1SNP 
###end p 24
###begin p 25
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 33 38 <span type="species:ncbi:9606">child</span>
###xml 324 331 <span type="species:ncbi:9606">patient</span>
Patient 40A is an eight-year-old child with bilateral anophthalmia. Clinical features included dilated ventricles with ventriculo-peritoneal shunt placement for hydrocephalus, microcephaly, atrophic optic nerves, chiasm, posterior corpus callosum and splenium, and abnormal electroencephalograms with no overt seizures. The patient has short stature and delayed motor and mental development. He has an unusual ataxic gait but is independently mobile with a walker. He has begun to speak in three to four word sentences.
###end p 25
###begin p 26
###xml 228 237 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 711 720 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 41 48 <span type="species:ncbi:9606">patient</span>
###xml 321 328 <span type="species:ncbi:9606">patient</span>
The amplified genomic fragments from the patient (40A) showed faster and slower migrating products comparing to that of the wild type observed in samples from the parents (40B and 40C) and normal controls (C1 and C2) with CSGE (Figure 2A). The heteroduplexes suggest a mutation in the fragment. The genomic DNA from this patient was sequenced bidirectionally. Two alleles were identified (Figure 2B), one with a wild type allele and one with a nucleotide substitution at c.310 G>T of the coding sequence, resulting in a nonsense amino acid change (p. Glu104X). The predicted shorter peptide is truncated at the end of the HMG domain, which results in the deletion of the entire COOH-terminal activation domain (Figure 2C). The mutation, located in the HMG domain, is not directly involved in DNA binding based on NMR-spectroscopy structure from the Protein Data Bank (PDB). Both parents were homozygous for the wild type allele.
###end p 26
###begin p 27
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 700 702 700 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 870 872 870 872 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 561 568 <span type="species:ncbi:9606">patient</span>
###xml 787 794 <span type="species:ncbi:9606">patient</span>
Mutation in the SOX2 HMG domain. Genomic DNA from affected patients, unaffected relatives, and healthy controls are amplified by PCR. PCR products are separated by electrophoresis in an 8% polyacrylamide gel for detection of heteroduplexes and homoduplexes. Genomic DNA samples are then sequenced for detection of sequence variants. A: Heteroduplexes detected by CSGE is shown. Lanes C1 and C2 represent the healthy controls; Lane 40A represents the proband; Lane 40B represents the mother of the proband; and Lane 40C is the father of the proband. Sample from patient 40A shows heteroduplex comparing to homoduplex observed in samples from the parents (40B and 40C) and normal controls (C1 and C2). B: Single nucleotide substitution at c.310 G>T of the coding sequence is identified in patient 40A, but not in the parents (40B and 40C) and normal controls (C1 and C2). C: Mutation at c.310 G>T results in a nonsense amino acid change at p. Glu104X as illustrated. HMG=high mobility group.
###end p 27
###begin p 28
###xml 673 682 673 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 31 36 <span type="species:ncbi:9606">child</span>
###xml 1044 1050 <span type="species:ncbi:9606">infant</span>
Patient 54A is a nine-year-old child with right anophthalmia and left microphthalmia. Her clinical features included a right middle fossa arachnoid cyst and partial absence of the posterior aspect of the corpus callosum including the splenium. She had mild hydrocephalus and partial complex seizures. Other abnormalities were growth and thyroid hormone deficiency, developmental delays, and a wide-based ataxic gait. She also presented with facial asymmetry with a beaked nose, small widely-spaced teeth, and diastasis recti. The parents were unaffected. CSGE analysis showed three slower migrating product bands in addition to the wild type, indicative of heterozygosity (Figure 3A). The affected sibling of the proband (54H), who was diagnosed with bilateral anophthalmia by ultrasound in utero, had two slower migrating bands and the wild type product. An amniocentesis was performed, and a chromosome study was that of a normal female with a 46XX karyotype. Her birthweight of 8 lbs 15 ounces and length of 52 cm are appropriate for a term infant. Her newborn hearing screening test was normal. An orbital ultrasound shortly after birth revealed the absence of globe structures bilaterally. A head MRI at age of four months showed partial agenesis of the corpus callosum and hypoplasia of the orbits. Minimal ocular tissue was noted in the orbit with visualization of the extraocular muscles and lacrimal glands. The optic nerves were not visualized. The maxillae were hypoplastic.
###end p 28
###begin p 29
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 818 820 818 820 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 1095 1097 1095 1097 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 651 658 <span type="species:ncbi:9606">patient</span>
Mutation in the SOX2 activation domain. Genomic DNA from affected patients, unaffected relatives, and healthy controls are amplified by PCR. PCR products are separated by electrophoresis in an 8% polyacrylamide gel for detection of heteroduplexes and homoduplexes. Genomic DNA samples are then sequenced for detection of sequence variants. A: Heteroduplexes detected by CSGE is shown. Lanes C1 and C2 represent the healthy controls; Lane 54A represents the proband; Lane 54B represents the mother of the proband; Lane 54C represents the father of the proband; and Lane 54H represents the affected sibling of the proband. The additional slower band in patient 54A may represent a conformational intermediate formed during gel electrophoresis, resulting in a different mobility compared to homoduplexes and the triplet. B: Sequence analysis shows two alleles in the proband 54A, the affected sibling 54H, and the clinically normal mother 54B. One allele is the wild type sequence and the other one is single nucleotide deletion at c.549delC. The father 54C is homozygous for the wild type allele. C: The single nucleotide deletion at c.549delC results in a frame shift mutation and premature termination at 19 amino acids downstream of the deletion site (p.Pro184ArgfsX19). The mutation is predicted to delete part of the C-terminal activation domain and to produce a truncated peptide.
###end p 29
###begin p 30
At approximately nine months, she began treatment with thyroid supplementation for hypothyroidism. She is of a low growth percentile with normal growth hormone levels. She had urticaria pigmentosa at 14 months of age. At the age of 16 months, she sat without support, rolled, and babbled with consonants and vowels. She finger feeds and has no feeding difficulties. Her development is delayed but is more advanced than that of her sister, the proband, at the equivalent age. The mother has normal vision and an unremarkable ophthalmologic examination. She has normal motor abilities and intellect. A head MRI scan of the mother was unremarkable.
###end p 30
###begin p 31
###xml 228 237 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 481 490 481 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
Sequence analysis detected two alleles in the proband, the affected sibling, and the clinically normal mother (54B). One allele was the wild type sequence and the other was a c.549delC (p.Pro184ArgfsX19) in the coding sequence (Figure 3B). The deletion changes the reading frame and results in a premature stop codon 19 amino acids downstream of the deletion site. The mutation is predicted to delete part of the COOH-terminal activation domain and to produce a truncated peptide (Figure 3C). The father (54C) of the proband was homozygous for the wild type allele.
###end p 31
###begin p 32
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient 49A is a 17-year-old female with bilateral anophthalmia. Her clinical features include a ventricular-septal defect, which resolved without surgical intervention, and fusion of two primary teeth of the left lower jaw. She is developmentally normal and is currently applying to four-year colleges. The parents were unaffected. A heterozygous sequence variant was identified in this individual in the 3'-UTR by CSGE (Figure 4A). Sequence analysis detected two alleles, one with a wild type sequence and one with a nucleotide substitution, c.*557G>A (Figure 4B). The sequence alteration does not predictably change the SOX2 protein and is not a previously described SNP (). A review of transcription factor databases did not uncover known regulatory elements associated with the nucleotide substitution. DNA was unavailable from additional unaffected family members of the proband.
###end p 32
###begin p 33
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 335 336 335 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 585 587 585 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 85 92 <span type="species:ncbi:9606">patient</span>
###xml 476 483 <span type="species:ncbi:9606">patient</span>
###xml 658 665 <span type="species:ncbi:9606">patient</span>
SOX2 mutation in the 3'- untranslated region (3'-UTR). Genomic DNA from the affected patient and healthy controls are amplified by PCR. PCR products are separated by electrophoresis in an 8% polyacrylamide gel for detection of heteroduplexes and homoduplexes. Genomic DNA samples are then sequenced for detection of sequence variants. A: Heteroduplexes detected by CSGE is shown. Lanes C1 and C2 represent the healthy controls and Lane 49A represents the proband. Sample from patient 49A shows heteroduplex comparing to homoduplex observed in samples from normal controls (C1 and C2). B: A nucleotide substitution at c.*557G>A of the 3'-UTR is identified in patient 49A, but not in normal controls (C). The sequence variant does not predictably change the SOX2 protein and is not a previously described SNP.
###end p 33
###begin p 34
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
To determine that the above sequence alterations detected in anophthalmia and microphthalmia patients were not single nucleotide polymorphisms (SNPs), 80 healthy control individuals were examined by direct sequencing analysis. None of the above sequence alterations were found in the normal control subjects. During this screening, we also detected SNP c.*469 C>A in 2 out of 34 patients. The SNP is a known variant and located at 3' UTR (SNP ).
###end p 34
###begin p 35
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 176 183 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
To evaluate sequence variations in CHX10, the same cohort of patients were screened by CSGE and direct sequencing. The majority of sequence variations were detected in exon 3 (Table 2), and the mutations were all synonymous, c.471 C>T (p.Ser157Ser, ) and c.579 G>A (p. Gln193Gln, novel SNP). Another sequence variation was found in exon 5, c.871 G>A (p. Asp291Asn, novel SNP), in one affected individual resulting in a non-synonymous polymorphism. Using healthy controls, the same sequence variant was found, suggesting non-causality.
###end p 35
###begin title 36
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
Sequence variations in CHX10.
###end title 36
###begin p 37
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
All sequence variations detected in CHX10 were in exons 3 and 5. Homoduplex indicates two identical alleles. Heteroduplex indicates different alleles. One allele is the wild type sequence and the other one is a sequence variant differing from the wild type one. The single nucleotide substitution at c.471 C>T is a known SNP (rs35435463) and results in a synonymous change in the protein sequence (p.Ser157Ser). The single nucleotide substitution at c.579 G>A is a novel SNP and results in a synonymous change in the protein sequence (p. Gln193Gln). Another novel sequence variation, c.871 G>A, is identified in exon 5 in one affected individual and results in a non-synonymous change in the protein sequence (p. Asp291Asn). This sequence variation is also identified in healthy controls. G=guanosine, T=thymidine, C=cytidine, A=adenosine, S=Ser=serine, Q=Gln=glutamine, D=Asp=aspartic Acid, N=Asn=asparagine. The asterisk indicates that the heteroduplex is detected in 4 of 50 healthy control samples.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 749 753 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX6</italic>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 762 766 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCOR</italic>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OTX2</italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIX6</italic>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD7</italic>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
The present study identified two novel mutations and two sequence variants (one novel, one known SNP) in SOX2 in 6 (two siblings) out of 34 anophthalmia/microphthalmia/ coloboma patients. The frequency of mutations in SOX2 in anophthalmia and microphthalmia patients is estimated at 10% for this study, which is consistent with previous reports [4,14,19]. A mutational analysis of CHX10 of the same cohort of anophthalmia/microphthalmia patients identified two synonymous sequence variants in exon 3 and one non-synonymous sequence variant in exon 5. The non-synonymous polymorphism was also present in normal controls, suggesting it is not causative. Further sequence analysis of other genes associated with anophthalmia and microphthalmia such as PAX6 [7,25], BCOR [26], OTX2 [27], SIX6 [28,29], and CHD7 [30,31] is ongoing in this study cohort to determine mutation associations.
###end p 39
###begin p 40
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1030 1034 1030 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1102 1106 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
Two mutations, a nonsense mutation and a frameshift mutation, were located in the coding region of SOX2, and both resulted in truncation of the SOX2 protein. The shortened protein product may result in loss of function. In animal studies, homozygous mice for SOX2 null allele are embryonic lethal [16] and heterozygous mice with one null allele are normal compared to that of the wild type [32]. Further reduction of the level of SOX2 expression by deleting a neural cell-specific enhancer on a heterozygous background resulted in reduced viability and neurodegeneration [32]. These observations suggest that the abnormal phenotype may become apparent when SOX2 expression falls below a certain threshold, or loss of function in one allele reduces SOX2 expression below that level. One of the mutations detected in this study was at the 3' UTR. Although the relationship between the mutation at the 3'-UTR and anophthalmia/ microphthalmia is indeterminate, one possibility is that the nucleotide substitution at c.*557G>A affects SOX2 expression. This is supported by the observation that the 3'UTR of SOX2 contains regulatory elements that enhance its transcriptional activity in embryonic stem cells [33].
###end p 40
###begin p 41
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 911 915 911 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Of interest is the transmission of a SOX2 mutation from an unaffected mother to her two daughters in the example of sibling patients 54A and 54H. Gonosomal mosaicism, evidenced by the presence of a mutation in buccal cells but not in white cell-derived DNA, has been reported for SOX2 in an unaffected parent [34]. We were able to identify this mutation in genomic DNA derived from white blood cells in the unaffected mother. This suggests that this mother may not be mosaic in this circumstance. We propose that the anophthalmia phenotype appears to be non-penetrant. Non-penetrant mutations have been reported previously in sonic hedgehog (SHH) [34] and in fibroblast growth factor receptor 1 (FGFR) [35]. This example underscores the importance of testing seemingly unaffected parents once a mutation is discovered in their offspring regardless of their phenotype and points out that some individuals with a SOX2 mutation may be non-penetrant.
###end p 41
###begin p 42
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 976 980 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1146 1150 1146 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1310 1314 1310 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1613 1615 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1832 1836 1832 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 1967 1969 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 2038 2042 2038 2042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 236 243 <span type="species:ncbi:9606">patient</span>
###xml 486 494 <span type="species:ncbi:9606">patients</span>
###xml 583 590 <span type="species:ncbi:9606">Patient</span>
###xml 639 646 <span type="species:ncbi:9606">Patient</span>
###xml 789 796 <span type="species:ncbi:9606">Patient</span>
###xml 817 824 <span type="species:ncbi:9606">patient</span>
###xml 959 965 <span type="species:ncbi:10090">murine</span>
###xml 1176 1184 <span type="species:ncbi:9606">patients</span>
###xml 1618 1625 <span type="species:ncbi:9606">Patient</span>
###xml 1791 1799 <span type="species:ncbi:9606">patients</span>
###xml 1843 1850 <span type="species:ncbi:9606">Patient</span>
###xml 1922 1930 <span type="species:ncbi:9606">patients</span>
Our patients with coding region mutations had SOX2 phenotypes consistent with previous studies [4,10-12]. All patients with mutations had bilateral anophthalmia and unilateral severe microphthalmia (40A, 49A, 54H) with the exception of patient 54A who had unilateral anophthalmia instead of bilateral anophthalmia. This suggests that SOX2 mutations cause a more severe disruption of normal eye development and that microphthalmia/anophthalmia are of a spectrum of the same disease. The patients with coding sequence mutations (40A, 54A, and 54H) had significant brain abnormalities. Patient 40A showed dilated ventricles and microcephaly. Patient 54A was diagnosed with a right middle fossa arachnoid cyst and partial absence of posterior aspect of corpus callosum including the splenium. Patient 54H, the sibling of patient 54A, had partial agenesis of the corpus callosum. Brain structure changes are also consistent with other studies and are supported by murine models of SOX2 deficiency with neurodegeneration and impaired brain neurogenesis [32]. Hormonal deficiencies and growth retardation are also important phenotypic associations with SOX2 coding sequence changes (patients 40A, 54A, and 54H). Ragge et al. [10] have reported a case of anophthalmia/microphthalmia caused by a frameshift mutation in SOX2 (case 9, c.628delA, p.Met210fs211X). The genetic location of that mutation is similar to the proband 54A and her sibling 54H (c.549delC, p.Pro184ArgfsX19) in this study. The neurological phenotypes in this study, including brain malformations and seizure activity, were also present in their case [10]. Patient 49A with a 3'-UTR mutation had a cardiac ventricular-septal defect with dental anomalies. Different forms of craniofacial and dental defects were also noted in some patients with coding region mutations of SOX2 gene. Patient 54A () had facial asymmetry and small, widely spaced teeth. One of the patients (case #1) reported by Ragge et al. [10] also showed craniofacial dysmorphisms and widely spaced teeth. The SOX2 UTR mutations appear to be associated with severe eye development but are perhaps less likely to manifest with neurological manifestations.
###end p 42
###begin p 43
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
In conclusion, this study confirms that heterozygous loss of function mutations in SOX2 cause anophthalmia and microphthalmia and represent approximately 10% of patients ascertained for anophthalmia and microphthalmia but may also be non-penetrant. Mutations in CHX10 are less frequently found. Genetic screening of other candidate genes and the identification of genetic factors influencing SOX2 expression may help to determine the susceptibility of various disease alleles in the occurrence of this severe form of eye malformation and also help to identify factors that may influence SOX2 expression. Further characterization of genetic interactions among causative genes may also help to further our understanding of the formation of the eye.
###end p 43
###begin title 44
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX2</italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHX10</italic>
###xml 12 19 <span type="species:ncbi:9606">Patient</span>
Appendix 1. Patient demographics and mutations and sequence variants in SOX2 and CHX10 genes.
###end title 44
###begin p 45
To access the data, click or select the words "". This will initiate the download of a compressed (.zip) archive that contains the file. This file should be uncompressed with an appropriate program (the particular program will depend on your operating system).
###end p 45
###begin title 46
Acknowledgments
###end title 46
###begin p 47
###xml 104 112 <span type="species:ncbi:9606">Children</span>
The authors would like to thank all families for their participation in the study. We wish to thank the Children's Hospital General Clinical Research Center for their support for this study. This work was supported by NIH Grants RO1 EY014685 and 2PEY01583, Research To Prevent Blindness Inc., The Mabel E. Leslie Endowment Funds, NIH/NCRR Mo1-RR-000240 (all T.L.Y.), and the Albert Einstein Society of the Albert Einstein Healthcare Network (A.S.).
###end p 47
###begin title 48
References
###end title 48
###begin article-title 49
Epidemiologic characteristics of anophthalmia and bilateral microphthalmia among 2.5 million births in California, 1989-1997.
###end article-title 49
###begin article-title 50
The epidemiology of anophthalmia and microphthalmia in Sweden.
###end article-title 50
###begin article-title 51
Anophthalmia and microphthalmia in the Alberta congenital anomalies surveillance system.
###end article-title 51
###begin article-title 52
Mutations in SOX2 cause anophthalmia.
###end article-title 52
###begin article-title 53
Hamosh a, Williams C. Association of anophthalmia and esophageal atresia.
###end article-title 53
###begin article-title 54
Two sibs with anophthalmia and pulmonary hypoplasia (the Matthew-Wood syndrome).
###end article-title 54
###begin article-title 55
Pax6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.
###end article-title 55
###begin article-title 56
Absence of deletion at the SOX2 locus in a case of microphthalmia and esophageal atresia.
###end article-title 56
###begin article-title 57
Manifestations in four males and an obligate carrier of the Lenz microphthalmia syndrome.
###end article-title 57
###begin article-title 58
SOX2 anophthalmia syndrome.
###end article-title 58
###begin article-title 59
SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies.
###end article-title 59
###begin article-title 60
Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene.
###end article-title 60
###begin article-title 61
Prenatal diagnosis of primary anophthalmia with a 3q27 interstitial deletion involving SOX2.
###end article-title 61
###begin article-title 62
Anophthalmia and microphthalmia.
###end article-title 62
###begin article-title 63
Regulatory networks in embryo-derived pluripotent stem cells.
###end article-title 63
###begin article-title 64
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Multipotent cell lineages in early mouse development depend on SOX2 function.
###end article-title 64
###begin article-title 65
Frizzled 5 signaling governs the neural potential of progenitors in the developing xenopus retina.
###end article-title 65
###begin article-title 66
Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development.
###end article-title 66
###begin article-title 67
SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.
###end article-title 67
###begin article-title 68
###xml 37 41 <span type="species:ncbi:9606">girl</span>
Isolated bilateral anophthalmia in a girl with an apparently balanced de novo translocation: 46,xx,t(3;11)(q27;p11.2).
###end article-title 68
###begin article-title 69
###xml 36 42 <span type="species:ncbi:10090">murine</span>
Developmental expression of a novel murine homeobox gene (ChHX10): Evidence for roles in determination of the neuroretina and inner nuclear layer.
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human microphthalmia associated with mutations in the retinal homeobox gene CHX10.
###end article-title 70
###begin article-title 71
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Vidgen d, Hoover F, Goldman D, Kalnins VI, Roderick TH, Taylor BA, Hankin MH, McInnes RR. Ocular retardation mouse caused by CHX10 homeobox null allele: Impaired retinal progenitor proliferation and bipolar cell differentiation.
###end article-title 71
###begin article-title 72
CHX10 mutations cause non-syndromic microphthalmia/ anophthalmia in Arab and Jewish kindreds.
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse small eye results from mutations in a paired-like homeobox-containing gene.
###end article-title 73
###begin article-title 74
Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR.
###end article-title 74
###begin article-title 75
Heterozygous mutations of OTX2 cause severe ocular malformations.
###end article-title 75
###begin article-title 76
###xml 44 49 <span type="species:ncbi:9606">human</span>
Genomic cloning and characterization of the human homeobox gene six6 reveals a cluster of six genes in chromosome 14 and associates SIX6 hemizygosity with bilateral anophthalmia and pituitary anomalies.
###end article-title 76
###begin article-title 77
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Analysis of the developmental six6 homeobox gene in patients with anophthalmia/microphthalmia.
###end article-title 77
###begin article-title 78
Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.
###end article-title 78
###begin article-title 79
Spectrum of CHD7 mutations in 110 individuals with charge syndrome and genotype-phenotype correlation.
###end article-title 79
###begin article-title 80
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
SOX2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain.
###end article-title 80
###begin article-title 81
Identification of SOX-2 regulatory region which is under the control of Oct-3/4-SOX-2 complex.
###end article-title 81
###begin article-title 82
Novel mutation in Sonic hedgehog in non-syndromic colobomatous microphthalmia.
###end article-title 82
###begin article-title 83
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.
###end article-title 83

